Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients
Condition: Celiac Disease Interventions: Drug: DONQ52; Drug: Placebo Sponsor: Chugai Pharmaceutical Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 21, 2022 Category: Research Source Type: clinical trials
A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet
Condition: Celiac Disease Interventions: Drug: TAK-062; Dietary Supplement: Simulated Inadvertent Gluten Exposure (SIGE) Gluten-Bar; Drug: TAK-062 Placebo; Dietary Supplement: Simulated Inadvertent Gluten Exposure (SIGE) Gluten-free Bar Sponsor: Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2022 Category: Research Source Type: clinical trials